{"id":7116,"date":"2022-02-14T17:50:35","date_gmt":"2022-02-14T16:50:35","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/02\/CP-MaaT-Pharma_Skyepharma-Partenariat.pdf"},"modified":"2022-02-14T17:50:35","modified_gmt":"2022-02-14T16:50:35","slug":"cp-maat-pharma_skyepharma-partenariat-2","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/maat-pharma-and-skyepharma-have-entered-a-partnership-to-establish-the-first-exclusive-microbiome-ecosystem-therapies-cgmp-manufacturing-facility-in-france\/cp-maat-pharma_skyepharma-partenariat-2\/","title":{"rendered":"CP-MaaT-Pharma_Skyepharma-Partenariat"},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-7116","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"\n